Review



mk2 sirna nucleotide  (Santa Cruz Biotechnology)


Bioz Verified Symbol Santa Cruz Biotechnology is a verified supplier  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Santa Cruz Biotechnology mk2 sirna nucleotide
    Figure 4 Phosphorylation by <t>MK2</t> attenuates the action of stimulatory phosphorylation by PKA
    Mk2 Sirna Nucleotide, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 4 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mk2 sirna nucleotide/product/Santa Cruz Biotechnology
    Average 90 stars, based on 4 article reviews
    mk2 sirna nucleotide - by Bioz Stars, 2026-03
    90/100 stars

    Images

    1) Product Images from "Phosphorylation of cAMP-specific PDE4A5 (phosphodiesterase-4A5) by MK2 (MAPKAPK2) attenuates its activation through protein kinase A phosphorylation"

    Article Title: Phosphorylation of cAMP-specific PDE4A5 (phosphodiesterase-4A5) by MK2 (MAPKAPK2) attenuates its activation through protein kinase A phosphorylation

    Journal: Biochemical Journal

    doi: 10.1042/bj20101184

    Figure 4 Phosphorylation by MK2 attenuates the action of stimulatory phosphorylation by PKA
    Figure Legend Snippet: Figure 4 Phosphorylation by MK2 attenuates the action of stimulatory phosphorylation by PKA

    Techniques Used: Phospho-proteomics

    Figure 5 MK2 phosphorylation of PDE4A5 alters its ability to regulate intracellular cAMP concentrations
    Figure Legend Snippet: Figure 5 MK2 phosphorylation of PDE4A5 alters its ability to regulate intracellular cAMP concentrations

    Techniques Used: Phospho-proteomics

    Figure 6 MK2 phosphorylation of PDE4A5 attenuates its ability to be reversibly recruited into intracellular aggregates by chronic rolipram treatment
    Figure Legend Snippet: Figure 6 MK2 phosphorylation of PDE4A5 attenuates its ability to be reversibly recruited into intracellular aggregates by chronic rolipram treatment

    Techniques Used: Phospho-proteomics

    Figure 7 MK2 phosphorylation of PDE4A5 and its ability to be sequestered by partner proteins
    Figure Legend Snippet: Figure 7 MK2 phosphorylation of PDE4A5 and its ability to be sequestered by partner proteins

    Techniques Used: Phospho-proteomics



    Similar Products

    90
    Santa Cruz Biotechnology mk2 sirna nucleotide
    Figure 4 Phosphorylation by <t>MK2</t> attenuates the action of stimulatory phosphorylation by PKA
    Mk2 Sirna Nucleotide, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mk2 sirna nucleotide/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    mk2 sirna nucleotide - by Bioz Stars, 2026-03
    90/100 stars
      Buy from Supplier

    Image Search Results


    Figure 4 Phosphorylation by MK2 attenuates the action of stimulatory phosphorylation by PKA

    Journal: Biochemical Journal

    Article Title: Phosphorylation of cAMP-specific PDE4A5 (phosphodiesterase-4A5) by MK2 (MAPKAPK2) attenuates its activation through protein kinase A phosphorylation

    doi: 10.1042/bj20101184

    Figure Lengend Snippet: Figure 4 Phosphorylation by MK2 attenuates the action of stimulatory phosphorylation by PKA

    Article Snippet: COS1 cells were transfected using either Polyfect® reagent (Qiagen) or DEAE-dextran (Sigma–Aldrich) as described previously [10,11]. siRNAs The PolyFect® method of mammalian cell transfection (Qiagen) was used for the transfection of COS1 cells with an MK2 siRNA nucleotide from Santa Cruz Biotechnology, as reported previously [12].

    Techniques: Phospho-proteomics

    Figure 5 MK2 phosphorylation of PDE4A5 alters its ability to regulate intracellular cAMP concentrations

    Journal: Biochemical Journal

    Article Title: Phosphorylation of cAMP-specific PDE4A5 (phosphodiesterase-4A5) by MK2 (MAPKAPK2) attenuates its activation through protein kinase A phosphorylation

    doi: 10.1042/bj20101184

    Figure Lengend Snippet: Figure 5 MK2 phosphorylation of PDE4A5 alters its ability to regulate intracellular cAMP concentrations

    Article Snippet: COS1 cells were transfected using either Polyfect® reagent (Qiagen) or DEAE-dextran (Sigma–Aldrich) as described previously [10,11]. siRNAs The PolyFect® method of mammalian cell transfection (Qiagen) was used for the transfection of COS1 cells with an MK2 siRNA nucleotide from Santa Cruz Biotechnology, as reported previously [12].

    Techniques: Phospho-proteomics

    Figure 6 MK2 phosphorylation of PDE4A5 attenuates its ability to be reversibly recruited into intracellular aggregates by chronic rolipram treatment

    Journal: Biochemical Journal

    Article Title: Phosphorylation of cAMP-specific PDE4A5 (phosphodiesterase-4A5) by MK2 (MAPKAPK2) attenuates its activation through protein kinase A phosphorylation

    doi: 10.1042/bj20101184

    Figure Lengend Snippet: Figure 6 MK2 phosphorylation of PDE4A5 attenuates its ability to be reversibly recruited into intracellular aggregates by chronic rolipram treatment

    Article Snippet: COS1 cells were transfected using either Polyfect® reagent (Qiagen) or DEAE-dextran (Sigma–Aldrich) as described previously [10,11]. siRNAs The PolyFect® method of mammalian cell transfection (Qiagen) was used for the transfection of COS1 cells with an MK2 siRNA nucleotide from Santa Cruz Biotechnology, as reported previously [12].

    Techniques: Phospho-proteomics

    Figure 7 MK2 phosphorylation of PDE4A5 and its ability to be sequestered by partner proteins

    Journal: Biochemical Journal

    Article Title: Phosphorylation of cAMP-specific PDE4A5 (phosphodiesterase-4A5) by MK2 (MAPKAPK2) attenuates its activation through protein kinase A phosphorylation

    doi: 10.1042/bj20101184

    Figure Lengend Snippet: Figure 7 MK2 phosphorylation of PDE4A5 and its ability to be sequestered by partner proteins

    Article Snippet: COS1 cells were transfected using either Polyfect® reagent (Qiagen) or DEAE-dextran (Sigma–Aldrich) as described previously [10,11]. siRNAs The PolyFect® method of mammalian cell transfection (Qiagen) was used for the transfection of COS1 cells with an MK2 siRNA nucleotide from Santa Cruz Biotechnology, as reported previously [12].

    Techniques: Phospho-proteomics